SBMFF
Price:
$0.69515
Market Cap:
$83.15B
Sino Biopharmaceutical Limited is an investment holding company that operates as an integrated pharmaceutical enterprise. It researches, develops, manufactures, and markets a wide range of modernized Chinese medicines and chemical medicines. The company's therapeutic areas of focus include oncology, liver disease, respiratory, and surgery/pain relief, with its primary market being mainland China. [9, 12, 15, 19]
Industry
Medical - Pharmaceuticals
IPO Date
2010-02-22
Stock Exchange
OTC
Ticker
SBMFF
According to Sino Biopharmaceutical Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 85.44B. This represents a change of -17.34% compared to the average of 103.36B of the last 4 quarters.
The mean historical Enterprise Value of Sino Biopharmaceutical Limited over the last ten years is 80.36B. The current 85.44B Enterprise Value has changed 10.53% with respect to the historical average. Over the past ten years (40 quarters), SBMFF's Enterprise Value was at its highest in in the June 2020 quarter at 165.23B. The Enterprise Value was at its lowest in in the December 2023 quarter at 3.13B.
Average
80.36B
Median
82.41B
Minimum
35.82B
Maximum
123.00B
Discovering the peaks and valleys of Sino Biopharmaceutical Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 135.49%
Maximum Annual Enterprise Value = 123.00B
Minimum Annual Increase = -36.96%
Minimum Annual Enterprise Value = 35.82B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 108.90B | 107.97% |
| 2024 | 52.37B | -11.80% |
| 2023 | 59.37B | -26.22% |
| 2022 | 80.47B | -6.40% |
| 2021 | 85.98B | -30.10% |
| 2020 | 123.00B | 2.37% |
| 2019 | 120.15B | 125.95% |
| 2018 | 53.17B | -36.96% |
| 2017 | 84.35B | 135.49% |
| 2016 | 35.82B | -17.00% |
The current Enterprise Value of Sino Biopharmaceutical Limited (SBMFF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
73.55B
5-year avg
77.42B
10-year avg
80.36B
Sino Biopharmaceutical Limited’s Enterprise Value is greater than Silo Pharma, Inc. (-1200453.00), greater than Inventiva S.A. (723.54M), greater than BioCardia, Inc. (13.59M), greater than UroGen Pharma Ltd. (2.22B), greater than SB Technology Holdings Inc. (232.26K), greater than Kaleido Biosciences, Inc. (-16775738.00), greater than Regen BioPharma, Inc. (927.64K), greater than Dominari Holdings Inc. (32.95M), greater than GT Biopharma, Inc. (4.08M), greater than Fortress Biotech, Inc. (-48412129.00), greater than Innovation Pharmaceuticals Inc. (-637496.00), greater than Karuna Therapeutics, Inc. (12.43B), greater than Akari Therapeutics, Plc (3.48M), greater than Salarius Pharmaceuticals, Inc. (-6810237.00), greater than Axcella Health Inc. (-2482600.00), greater than Magenta Therapeutics, Inc. (-66820976.00), greater than Histogen Inc. (-7392565.00), greater than Can-Fite BioPharma Ltd. (2.03M), greater than BiondVax Pharmaceuticals Ltd. (22.48M), greater than Oramed Pharmaceuticals Inc. (179.48M), greater than MediWound Ltd. (177.33M), greater than BioLineRx Ltd. (14.58M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -1200453.00 | $2.08M | |
| 723.54M | $196.49M | |
| 13.59M | $17.41M | |
| 2.22B | $2.11B | |
| 232.26K | $232.26K | |
| -16775738.00 | $4.26K | |
| 927.64K | $94.62K | |
| 32.95M | $55.40M | |
| 4.08M | $9.04M | |
| -48412129.00 | $140.05M | |
| -637496.00 | $155.50K | |
| 12.43B | $12.60B | |
| 3.48M | $10.48M | |
| -6810237.00 | $4.92M | |
| -2482600.00 | $12.50M | |
| -66820976.00 | $42.44M | |
| -7392565.00 | $85.44K | |
| 2.03M | $2.93M | |
| 22.48M | $4.97M | |
| 179.48M | $193.99M | |
| 177.33M | $172.13M | |
| 14.58M | $10.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sino Biopharmaceutical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sino Biopharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sino Biopharmaceutical Limited's Enterprise Value?
What is the highest Enterprise Value for Sino Biopharmaceutical Limited (SBMFF)?
What is the 3-year average Enterprise Value for Sino Biopharmaceutical Limited (SBMFF)?
What is the 5-year average Enterprise Value for Sino Biopharmaceutical Limited (SBMFF)?
How does the current Enterprise Value for Sino Biopharmaceutical Limited (SBMFF) compare to its historical average?